Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the first volunteers have been enrolled in the...
Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir in Patients with Mild to Moderate COVID-19
Glenmark Pharmaceuticals Ltd. a global research-led pharmaceutical company announced top-line results from a Phase 3 clinical trial in mild to moderate COVID-19 patients conducted...
US doubles COVID vaccine fund as Moderna enters final phase of clinical trial
The United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by American firm Moderna, which...
Heron Therapeutics initiates phase 2 GUARDS-1 study of Cinvanti to treat COVID-19
Heron Therapeutics, a commercial-stage biotechnology company, announced the initiation of the GUARDS-1 Study, a phase 2 clinical study evaluating Cinvanti (aprepitant) injectable emulsion in...
Lilly’s Mirikizumab Superior to Cosentyx in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis
Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the primary and all key...
Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19
Gilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This open-label study evaluated 5-day...
Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO in Multiple Myeloma
Takeda Pharmaceutical Company Limited announced it will orally present the results of two studies at the 25th Congress of the European Hematology Association (EHA)....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...